(Q34226184)

English

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

E Haupt

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

W Köberich

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Beyer

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

K Schöffling

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 December 1971

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

449-454

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Microdetermination of long-chain fatty acids in plasma and tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical experiences with oral antidiabetic HB 419 (glibenclamide)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Mechanism of action of hypoglycemic sulfonyl urea compounds, D 860 & BZ 55.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[On radio-immunologic determination of insulin in blood].

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides]

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simplified method for immuno-assay of human serum insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/5004178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01212061

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34226184&oldid=2196397827"